Citeline Podcasts

On this week's podcast, the team discusses the confirmation of Robert Califf as FDA commissioner and his priorities, the president's Precision Medicine Initiative at the White House, the long-awaited release of the new global quality standard for medical devices, unannounced audits in Europe, device firms at the Supreme Court, an interesting deal for ResMed and more.

On this week's podcast, we discussed the next CEO of AdvaMed, chronic care policy development, off-label communication oversight proposals and more.

On this week's podcast, we discussed the next CEO of AdvaMed, chronic care policy development, off-label communication oversight proposals and more.

On this week's podcast, we discussed the next CEO of AdvaMed, chronic care policy development, off-label communication oversight proposals and more.

In an exclusive with “The Gray Sheet” former FDA commissioner and current Duke-Margolis Center director Mark McClellan spoke about a white paper released by a working group that proposes new policies regarding off-label communication of drug and medical devices.

In an exclusive with “The Gray Sheet” former FDA commissioner and current Duke-Margolis Center director Mark McClellan spoke about a white paper released by a working group that proposes new policies regarding off-label communication of drug and medical devices.

In an exclusive with “The Gray Sheet” former FDA commissioner and current Duke-Margolis Center director Mark McClellan spoke about a white paper released by a working group that proposes new policies regarding off-label communication of drug and medical devices.

In an exclusive with “The Gray Sheet” former FDA commissioner and current Duke-Margolis Center director Mark McClellan spoke about a white paper released by a working group that proposes new policies regarding off-label communication of drug and medical devices.

On this week's podcast, "The Gray Sheet" team spoke about photography during FDA inspections, device regulatory reform action in the Senate, FDA's budget, clinical decision support tools, combination products, pelvic mesh lawsuits and traumatic brain injury devices, among other topics.

On this week's podcast, "The Gray Sheet" team spoke about photography during FDA inspections, device regulatory reform action in the Senate, FDA's budget, clinical decision support tools, combination products, pelvic mesh lawsuits and traumatic brain injury devices, among other topics.